argenx SE (ARGNF) Financials

ARGNF Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 ? ?
Dec. 31, 2025 8.7 billion 1.4 billion
Sept. 30, 2025 ? ?
June 30, 2025 7.2 billion 1.1 billion

ARGNF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 ? ?
Dec. 31, 2025 386.1 million ?
Sept. 30, 2025 ? ?
June 30, 2025 462.9 million ?

ARGNF Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 366.0 million
Dec. 31, 2025 883.4 million
Sept. 30, 2025 295.2 million
June 30, 2025 447.4 million

ARGNF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 - - -
Dec. 31, 2025 4.4 billion 36.3 million 36.3 million
Sept. 30, 2025 - - -
June 30, 2025 3.9 billion - 43.2 million

ARGNF Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 ?
Dec. 31, 2025 61.9 million
Sept. 30, 2025 ?
June 30, 2025 61.2 million

ARGNF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 443.0 million 355.0 million -
Dec. 31, 2025 609164 732.5 million 771.3 million -
Sept. 30, 2025 - 355.7 million 336.3 million -
June 30, 2025 5.6 million 327.7 million 321.4 million -

ARGNF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 1.3 billion 121.0 million
Dec. 31, 2025 2.4 billion 260.9 million
Sept. 30, 2025 1.1 billion 109.4 million
June 30, 2025 948.0 million 110.7 million

ARGNF

Price: $900

52 week price:
532.40
900.00

Earnings Per Share: 22.49 USD

P/E Ratio: 35.71

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 51.7 billion

Links: